Secondary Prevention of Hyperkalemia With Sodium Polystyrene Sulfonate in Cardiac and Kidney Patients on Renin‐Angiotensin‐Aldosterone System Inhibition Therapy

BACKGROUND: Hyperkalemia, induced by renin‐angiotensin‐aldosterone system inhibition (RAAS‐I) in patients with chronic kidney disease (CKD), or cardiac disease often leads to withdrawal of RAAS‐I therapy. Sodium polystyrene sulfonate (SPS) is a potassium‐binding resin used for the treatment of hyper...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cardiol
Main Authors: Chernin, Gil, Gal‐Oz, Amir, Ben‐Assa, Eyal, Schwartz, Idit F., Weinstein, Talia, Schwartz, Doron, Silverberg, Donald S.
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Periodicals, Inc. 2011
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652546/
https://ncbi.nlm.nih.gov/pubmed/22057933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.20987
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados